| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698043 | Clinical Oncology | 2017 | 9 Pages |
Abstract
Poor performance status, low BMI and low muscle attenuation identify patients at increased risk of premature death after CRT. Risk factors for adverse outcomes should inform personalised discussions with patients about the potential harms as well as the intended benefits of treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J.C.S. Bowden, L.J. Williams, A. Simms, A. Price, S. Campbell, M.T. Fallon, K.C.H. Fearon,